Approval in principle for overseas JV in Nigeria with Blueseal Pharmaceuticals
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alpa Laboratories has approved in principle exploring a joint venture to incorporate Alpa Biopharm Limited in Nigeria, in association with Blueseal Pharmaceuticals Limited, Nigeria. The proposed entity will undertake pharmaceutical and healthcare related business. No investment has been made so far and the overseas company is not yet incorporated. Final capital structure, shareholding and governance terms will be decided separately, subject to statutory and regulatory approvals.
Positive signal of overseas expansion into Nigeria, though early stage with no investment yet and final terms pending, so limited immediate impact.